Transaction · 0001213900-26-091211

Fong Hei Yue Tina

Fong Hei Yue Tina, CMO, reported a transaction classified as grant at NewGenIvf Group Ltd involving 272140.000000 shares for an estimated $0.00. Reported holdings after the transaction were 345787.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ACMO
NIVFNewGenIvf Group Ltd
Filing timeAug 18
Trade dateAug 17, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$0.54
Pre-filing
1mo ago +144.4%1w ago +11.1%1d ago +7.4%
Returns since
7d -9.3%30d +146.3%90d +146.3%180d +146.3%1y +146.3%

NIVF price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
NIVF since 2026-08-18Filed 16 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0001213900-26-091211
Stock Options (Right to Buy)
Transaction date
Aug 17, 2026
Filed Aug 18, 2026, 08:01 PM · 1d delay
Shares
272k sh
$0 per share
Estimated value
$0
Computed from shares × price
Holdings after
345k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Derivative Transaction Direct Ownership Large Holdings Increase
-6score
Filing-only score

-6

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Marketing Officer

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    Reflects the grant of stock options to acquire 272,140 Class B Ordinary Shares of the Issuer at an exercise price of US$0.0001 per share, made pursuant to the Issuer's 2024 Share Incentive Plan and th…

Original filing · 0001213900-26-091211
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

NIVF